Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
- 5 July 2008
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 35 (3), 161-174
- https://doi.org/10.1016/j.ejps.2008.06.015
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- LAT1 gene variants—potential factors influencing the clinical course of phenylketonuriaJournal of Inherited Metabolic Disease, 2006
- An active transport system in the blood–brain barrier may reduce levodopa availabilityExperimental Neurology, 2005
- Apical and basolateral 4F2hc and the amino acid exchange of L-DOPA in renal LLC-PK1 cellsAmino Acids, 2005
- Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cellsAmino Acids, 2005
- In Silico Predictions of Blood-Brain Barrier Penetration: Considerations to “Keep in Mind”Journal of Pharmacology and Experimental Therapeutics, 2005
- Mediation of Highly Concentrative Uptake of Pregabalin by L-Type Amino Acid Transport in Chinese Hamster Ovary and Caco-2 CellsJournal of Pharmacology and Experimental Therapeutics, 2005
- Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity.The Journal of Toxicological Sciences, 2003
- Cysteine residues in the C-terminus of the neutral- and basic-amino-acid transporter heavy-chain subunit contribute to functional properties of the system b0,+-type amino acid transporterBiochemical Journal, 2000
- Human LAT1, a Subunit of System L Amino Acid Transporter: Molecular Cloning and Transport FunctionBiochemical and Biophysical Research Communications, 1999
- Distribution Volume of Radiolabeled Large Neutral Amino Acids in Brain TissueJournal of Cerebral Blood Flow & Metabolism, 1998